ORCHESTRA BIOMED HOLDINGS IN (OBIO) Stock Analyst Earnings Estimates
NASDAQ:OBIO - Nasdaq - US68572M1062 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.53M 552.56% | 2.76M -21.81% | 2.638M -4.42% | 3.178M 20.47% | 3.542M 11.45% | 3.611M 1.95% | 18.536M 413.32% | 57.359M 209.45% | 121.47M 111.77% | 134.84M 11.01% | 175.75M 30.34% | |
| EBITDA YoY % growth | -32.44M -50.05% | -51.219M -57.89% | -63.993M -24.94% | -82.824M -29.43% | -89.556M -8.13% | -92.31M -3.08% | -85.17M 7.73% | -55.59M 34.73% | -11.22M 79.82% | 31.518M 380.91% | 68.136M 116.18% | |
| EBIT YoY % growth | -32.66M -49.82% | -51.506M -57.70% | -64.301M -24.84% | -82.75M -28.69% | -84.583M -2.22% | -81.854M 3.23% | -65.893M 19.50% | -32.285M 51.00% | 17.389M 153.86% | 30.6M 75.97% | 67.014M 119.00% | |
| Operating Margin | -925.21% | -1,866.16% | -2,437.49% | -2,603.84% | -2,388.00% | -2,266.80% | -355.48% | -56.29% | 14.32% | 22.69% | 38.13% | |
| EPS YoY % growth | N/A | -1.50 84.66% | -1.66 -10.67% | -2.04 -22.70% | -1.77 13.03% | -1.76 0.67% | -1.26 28.12% | -0.51 59.68% | 0.49 196.00% | 0.42 -14.58% | 0.88 109.76% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.51 -14.17% | -0.53 -28.09% | -0.51 -22.50% | -0.49 -0.92% |
| Revenue Q2Q % growth | 709.512K -8.80% | 663.816K -32.74% | 786.828K 211.00% | 880.77K 1.47% |
| EBITDA Q2Q % growth | -20.808M -24.52% | -21.522M -33.53% | -21.318M -30.23% | -23.766M -26.16% |
| EBIT Q2Q % growth | -20.725M -22.93% | -21.091M -29.06% | -21.406M -28.36% | -22.434M -18.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.49 -28.95% | -0.49 | 0.00 | 0.13% |
| Q4 2024 Q2Q % growth | -0.42 -13.51% | -0.44 | 0.02 | 3.57% |
| Q3 2024 Q2Q % growth | -0.41 -7.89% | -0.44 | 0.03 | 6.52% |
| Q2 2024 Q2Q % growth | -0.45 -28.57% | -0.40 | -0.05 | -12.33% |
| Q1 2024 Q2Q % growth | -0.38 5.00% | -0.41 | 0.03 | 6.39% |
| Q4 2023 Q2Q % growth | -0.37 78.79% | -0.38 | 0.01 | 3.65% |
| Q3 2023 Q2Q % growth | -0.38 | -0.40 | 0.02 | 4.47% |
| Q2 2023 Q2Q % growth | -0.35 | -0.42 | 0.07 | 17.32% |
| Q1 2023 Q2Q % growth | -0.40 | -0.29 | -0.11 | -37.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 868K 40.00% | 537.03K | 330.97K | 61.63% |
| Q4 2024 Q2Q % growth | 253K -3.44% | 857.993K | -604.993K | -70.51% |
| Q3 2024 Q2Q % growth | 987K 135.56% | 725.73K | 261.27K | 36.00% |
| Q2 2024 Q2Q % growth | 778K -14.97% | 870.57K | -92.57K | -10.63% |
| Q1 2024 Q2Q % growth | 620K -46.74% | 955.403K | -335.403K | -35.11% |
| Q4 2023 Q2Q % growth | 262K -76.18% | 1.014M | -752K | -74.16% |
| Q3 2023 Q2Q % growth | 419K -63.88% | 912.9K | -493.9K | -54.10% |
| Q2 2023 Q2Q % growth | 915K 128.75% | 720.12K | 194.88K | 27.06% |
| Q1 2023 Q2Q % growth | 1.164M 33.79% | 693.6K | 470.4K | 67.82% |
| Q4 2022 Q2Q % growth | 1.1M 144.90% | 1.204M | -104K | -8.64% |
| Q3 2022 Q2Q % growth | 1.16M -12.78% | % | ||
| Q2 2022 Q2Q % growth | 400K 140.82% | % | ||
| Q1 2022 Q2Q % growth | 870K -34.09% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -4.94% | 0% | -0.47% |
| Revenue | 0% | -22.91% | 0% | 5.79% |